22146 Federal Register / Vol. 76, No. 76 / Wednesday, April 20, 2011 / Notices 

named as respondents Astra Tobacco 

Corporation of Chapel Hill, North 

Carolina; delfortgroup AG of Traun, 

Austria; LIPtec GmbH and Julius Glatz 

GmbH of Neidenfels, Germany. 

On March 22, 2011, the ALJ issued an 

ID (Order No. 5) granting complainant 

Schweitzer’s motion to amend the 

complaint and notice of the 

investigation to add seven additional 

respondents to the investigation. The 

new respondents are Dosal Tobacco 

Corp.; Farmer’s Tobacco Co.; S&M 

Brands, Inc.; Tantus Tobacco, LLC; 

KneX Worldwide, LLC; Dr. Franz 

Feurstein GmbH; and 

PapierfabrikWattens GmbH & Co. KG. 

No party petitioned for review of the 

subject ID. The Commission has 

determined not to review the ID. 

The authority for the Commission’s 

determination is contained in section 

337 of the Tariff Act of 1930, as 

amended (19 U.S.C. 1337), and in 

section 210.42(h) of the Commission’s 

Rules of Practice and Procedure (19 CFR 

210.42(h)). 

By order of the Commission. 

Issued: April 15, 2011. 

James R. Holbein, 

Acting Secretary to the Commission. 

[FR Doc. 2011–9584 Filed 4–19–11; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[USITC SE–11–010] 

Government in the Sunshine Act 

Meeting Notice 

AGENCY HOLDING THE MEETING: United 

States International Trade Commission. 

TIME AND DATE: April 28, 2011 at 11 a.m. 

PLACE: Room 110, 500 E Street SW., 

Washington, DC 20436, Telephone: 

(202) 205–2000. 

STATUS: Open to the public. 

MATTERS TO BE CONSIDERED: 

1. Agendas for future meetings: none. 

2. Minutes. 

3. Ratification List. 

4. Vote in Inv. Nos. 701–TA–475 and 

731–TA–1177 (Final) (Aluminum 

Extrusions from China). The 

Commission is currently scheduled to 

transmit its determinations and 

Commissioners’ opinions to the 

Secretary of Commerce on or before May 

13, 2011. 

5. Outstanding action jackets: none. 

In accordance with Commission 

policy, subject matter listed above, not 

disposed of at the scheduled meeting, 

may be carried over to the agenda of the 

following meeting. Earlier Notification 

of this meeting was not possible. 

By order of the Commission: 

Issued: April 18, 2011. 

William R. Bishop, 

Hearings and Meetings Coordinator. 

[FR Doc. 2011–9726 Filed 4–18–11; 4:15 pm] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances Notice of Application 

Pursuant to § 1301.33(a) of Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on February 24, 2011, 

Stepan Company, Natural Products 

Dept., 100 W. Hunter Avenue, 

Maywood, New Jersey 07607, made 

application by renewal to the Drug 

Enforcement Administration (DEA) as a 

bulk manufacturer of the following basic 

classes of controlled substances: 

Drug Schedule 

Cocaine (9041) .............................. II 

Ecgonine (9180) ............................ II 

The company plans to manufacture 

the listed controlled substances in bulk 

for distribution to its customers. 

Any other such applicant, and any 

person who is presently registered with 

DEA to manufacture such substances, 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than June 20, 2011. 

Dated: April 13, 2011. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2011–9619 Filed 4–19–11; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a), Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on November 3, 2010, 

Noramco Inc., 500 Swedes Landing 

Road, Wilmington, Delaware 19801– 

4485, made application by letter to the 

Drug Enforcement Administration 

(DEA) as a bulk manufacturer of the 

following basic classes of controlled 

substances: 

Drug Schedule 

Amphetamine (1100) .................... II 

Phenylacetone (8501) .................. II 

The company plans to manufacture 

the listed controlled substances in bulk 

for distribution to its customers. 

Any other such applicant, and any 

person who is presently registered with 

DEA to manufacture such substances, 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than June 20, 2011. 

Dated: April 13, 2011. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2011–9610 Filed 4–19–11; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated June 17, 2010, and 

published in the Federal Register on 

June 28, 2010, 75 FR 36679, Lin Zhi 

International Inc., 670 Almanor Avenue, 

Sunnyvale, California 94085, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the basic classes of controlled 

substances listed in schedules I and II: 

Drug Schedule 

Tetrahydrocannabinols (7370) ..... I 

3,4- 

Methylenedioxymethamphetamine (MDMA) (7405).

I 

Cocaine (9041) ............................. II 

Oxycodone (9143) ........................ II 

Hydrocodone (9193) ..................... II 

Methadone (9250) ........................ II 

Dextropropoxyphene, bulk (nondosage forms) (9273).II 

Morphine (9300) ........................... II 

The company plans to manufacture 

the listed controlled substances as bulk 

reagents for use in drug abuse testing. 


srobinson on DSKHWCL6B1PROD with NOTICES